EGFR inhibitor

This page covers all EGFR inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting EGFR.

Targets

EGFR

Phase 2 pipeline (7)

• Afatinib treatment · Sheba Medical Center · Oncology
  Epidermal growth factor receptor (EGFR) inhibitor
• AZD3759 · Guangdong Association of Clinical Trials · Oncology
  AZD3759 is a small molecule inhibitor of the EGFR pathway.
• Cetuximab Induction · Arbeitsgemeinschaft medikamentoese Tumortherapie · Oncology
  Cetuximab is a monoclonal antibody that targets and binds to the epidermal growth factor receptor (EGFR), preventing its activation and subsequent signaling.
• Cetuximab Injection [Erbitux] · Shanghai Henlius Biotech · Oncology
  Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), preventing cancer cell growth and proliferation.
• IV cetuximab · Association pour la Recherche sur le Temps Biologique et la Chronothérapie · Oncology
  Inhibits epidermal growth factor receptor (EGFR)
• Amivantamab IV · Janssen Research & Development, LLC · Oncology
  Targeting EGFR
• Anti-EGFR-Containing Regimen · Hoffmann-La Roche · Oncology
  Inhibits the epidermal growth factor receptor (EGFR)